ELOVL1 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
Iodide (SCHEMBL2380459)	0.53	10/20
SCHEMBL2864732	0.46	10/20
SCHEMBL1356550	0.40	10/20
SCHEMBL1944088	0.45	9/20
SCHEMBL83628	0.52	7/20
SCHEMBL83794	0.52	7/20
SCHEMBL84497	0.51	7/20
SCHEMBL1259168	0.46	7/20
SCHEMBL1062877	0.50	6/20
SCHEMBL1505919	0.44	6/20
SCHEMBL621931	0.44	6/20
Hydrochloric Acid (SCHEMBL624262)	0.43	6/20
SCHEMBL1964025	0.39	6/20
SCHEMBL623234	0.51	5/20
SCHEMBL624150	0.47	5/20
SCHEMBL1063920	0.47	5/20
SCHEMBL725497	0.45	5/20
SCHEMBL1462241	0.44	5/20
SCHEMBL2371733	0.44	5/20
SCHEMBL2570788	0.43	5/20

Clinical trials — most relevant to ELOVL1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effects of Omega-3 Fatty Acids on the Human Gene Expression	PHASE4	COMPLETED
Bezafibrate Trial in CPT2 Deficiency	PHASE3	UNKNOWN
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention	PHASE2	COMPLETED
Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)	PHASE2	COMPLETED
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver	PHASE2	COMPLETED
Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy	PHASE1	COMPLETED
The Effects of Milk Protein Versus Soy Protein on Essential Omega-3 Fatty Acid Metabolism	nan	ACTIVE_NOT_RECRUITING
Omega-3 vs Very Low Calorie Diet for Liver Size Reduction	nan	UNKNOWN
Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing	nan	COMPLETED
Exercise Intolerance Study in Long Chain Fatty Acid Oxidation Disorders	nan	RECRUITING
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study	nan	COMPLETED
EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish)	nan	UNKNOWN
Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo	nan	COMPLETED
Dietary Intake of Whole Walnuts in Adult Subjects Under Low Cardiovascular Risk	nan	COMPLETED
Canola Oil Multicentre Intervention Trial	nan	COMPLETED
Fatty Acid Oxidation Defects and Insulin Sensitivity	nan	COMPLETED
Lipid Mediators in Multiple Sclerosis	nan	COMPLETED
Effects of Fish Oils on Inflammation and Insulin Resistance	nan	COMPLETED
Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury	nan	COMPLETED
Serum FFA Desaturase Activity Index in Patients on High Dose Corticosteroids	nan	UNKNOWN
Stearoyl-CoA Desaturase and Energy Metabolism in Humans	nan	COMPLETED
Genotype-related Effects of PUFA	nan	COMPLETED
Obesity, Inflammation and Aging: Effects of Physical Exercise and Omega-3 Fatty Acids.	nan	COMPLETED
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise	nan	COMPLETED
Action of Essential Fatty Acids on the Expression of Antioxidant Genes and Athletic Performance	nan	COMPLETED
A Pilot Study of High-Dose Omega-3 (Soloways ™) Polyunsaturated Fatty Acids in Patients with Dyslipidemia Carrying FADS1/FADS2 Variants	nan	COMPLETED
Krill Oil Supplementation: Effects on Breast Milk Composition	nan	COMPLETED
Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 Polymorphisms	nan	COMPLETED
Heart & Health Study	nan	COMPLETED
Effect of n-3 Polyunsaturated Fatty Acids Supplementation on Human Milk Composition of Lactating Women	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a ELOVL1 binder may also engage these)

Protein	Name	Similarity
Q9JLJ5	—	1.000	Q9JLJ5 →
D4ADY9	—	0.997	D4ADY9 →
Q9D2Y9	—	0.993	Q9D2Y9 →
A0JNC4	—	0.992	A0JNC4 →
A1L3X0	—	0.990	A1L3X0 →
O35949	—	0.986	O35949 →
Q9NXB9	—	0.985	Q9NXB9 →
Q4DHY3	—	0.982	Q4DHY3 →
Q4D5J7	—	0.982	Q4D5J7 →
ELOVL3	Very long chain fatty acid elongase 3	0.982	landscape →
Q4DUK4	—	0.981	Q4DUK4 →
Q9JLJ4	—	0.980	Q9JLJ4 →
Q32NI8	—	0.980	Q32NI8 →
Q03574	—	0.980	Q03574 →
Q9VH58	—	0.979	Q9VH58 →
B4QVX4	—	0.979	B4QVX4 →
Q5M8U1	—	0.978	Q5M8U1 →
Q9VHX7	—	0.977	Q9VHX7 →
A0A0C5PHQ7	—	0.976	A0A0C5PHQ7 →
Q54TC9	—	0.976	Q54TC9 →
Q4QJ85	—	0.976	Q4QJ85 →
Q9VV87	—	0.975	Q9VV87 →
D4A612	—	0.975	D4A612 →
Q9XVQ9	—	0.975	Q9XVQ9 →
Q57UP6	—	0.975	Q57UP6 →
P49191	—	0.974	P49191 →
G5EEE5	—	0.974	G5EEE5 →
Q20303	—	0.972	Q20303 →
Q4D321	—	0.971	Q4D321 →
Q1HRV8	—	0.971	Q1HRV8 →